Advanced Oncotherapy PLC (GB:AVO)
LSE:AVO
UK Market

Advanced Oncotherapy Stock Analysis & Ratings

GB:AVO Stock Chart & Stats

Day’s Range21.2p - 21.2p
52-Week Range20.00p - 50.00p
Previous Close21.25p
Volume51.79K
Average Volume (3M)235.68K
Market Cap99.91M
P/E Ratio-3.0
Beta8.85
Next EarningsJun 29, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score6
EPS (TTM)-0.08


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:AVO FAQ

What was Advanced Oncotherapy’s price range in the past 12 months?
Advanced Oncotherapy lowest stock price was 20.00p and its highest was 50.00p in the past 12 months.
    What is Advanced Oncotherapy’s market cap?
    Advanced Oncotherapy’s market cap is 99.91M.
      What is Advanced Oncotherapy’s price target?
      Currently, no data Available
      What do analysts say about Advanced Oncotherapy?
      Not enough analysts have published a price target to provide an average price target.
      When is Advanced Oncotherapy’s upcoming earnings report date?
      Advanced Oncotherapy’s upcoming earnings report date is Jun 29, 2022 which is in 33 days.
        How were Advanced Oncotherapy’s earnings last quarter?
        Currently, no data Available
        Is Advanced Oncotherapy overvalued?
        According to Wall Street analysts Advanced Oncotherapy’s price is currently Overvalued.
          Does Advanced Oncotherapy pay dividends?
          Advanced Oncotherapy does not currently pay dividends.
          What is Advanced Oncotherapy’s EPS estimate?
          Advanced Oncotherapy’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Advanced Oncotherapy have?
          Advanced Oncotherapy has 470,150,000 shares outstanding.
            What happened to Advanced Oncotherapy’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Advanced Oncotherapy?
            Currently, no hedge funds are holding shares in GB:AVO

            ---

            Advanced Oncotherapy Stock Analysis

            Smart Score
            6
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10
            Price Target
            No data currently available

            Analyst Forecast

            N/A
            Currently Not Enough Data Available

            Blogger Sentiment

            N/A
            Currently Not Enough Data Available

            Hedge Fund Holdings

            N/A
            Currently Not Enough Data Available

            Insider Transactions

            ▲ Bought Shares
            Worth £93.1K over the Last 3 Months

            Retail Investors

            N/A
            Currently Not Enough Data Available

            News Sentiment

            N/A
            Currently Not Enough Data Available

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -36.56%
            12-Months-Change

            Fundamentals

            Return on Equity
            N/A
            Trailing 12-Months
            Asset Growth
            N/A
            Trailing 12-Months
            The Advanced Oncotherapy stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Advanced Oncotherapy PLC

            Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing in curing critical unmet conditions. The company's only business segments being Proton Therapy.

            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            ANGLE plc
            AFC Energy
            OptiBiotix Health
            ReNeuron Group

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis